CellCarta Biosciences SA
62.9 FTECellCarta Biosciences reported total assets of €22.4m at the end of the 2023 financial year (annual accounts filed with the NBB on 30 Oct 2026), with 62.9 full-time equivalents.
By total assets for 2023, CellCarta Biosciences ranks among the 100 largest of the 895 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of CellCarta Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Total assets +218 % Headcount (avg FTE) +102 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
CellCarta Biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2023filed on 30 Oct 2026
- Year ended 31 Dec 2022filed on 04 Feb 2025
- Year ended 31 Dec 2021filed on 12 Sep 2024
- Year ended 31 Dec 2020filed on 17 Jan 2023
- Year ended 30 Jun 2019filed on 27 Feb 2020
CellCarta Biosciences's financial analysis
- Solvency4.7%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of CellCarta Biosciences
CellCarta Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0661.567.021
- VAT number
- BE0661567021
- Peppol
- Registered · 0208:0661567021 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 18 Aug 2016
- Registered office
- 6041 Charleroi
- Size
- Medium · 62.9 FTE
- Latest accounts
- 2023 · filed on 30 Oct 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
CellCarta Biosciences (SA) has been based in Charleroi since 2016, active in: research and experimental development on biotechnology. For 2023, it reports a net profit of 440,694 € and equity of €1.05m; its revenue is not published. With 62.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 4.7%, below the median of its sector (58.2%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to CellCarta Biosciences
Companies in the same business, of comparable size and area, outside its group.
- Inari Agriculture, NV Research and experimental development on natural sciences and engineering Ghent · balance sheet €12.1m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- Augustine Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €30.9m
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
- ERC Belgium Research and experimental development on natural sciences and engineering Gembloux · balance sheet €11.6m
- iTeos Belgium Research and experimental development on natural sciences and engineering Charleroi · balance sheet €46.3m
Frequently asked questions about CellCarta Biosciences
What is the revenue of CellCarta Biosciences?
CellCarta Biosciences files its accounts in a format where revenue is optional: it is not published for 2023.
What is the VAT number of CellCarta Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0661567021 for CellCarta Biosciences, if the company is VAT-registered. Its company number (CBE) is 0661.567.021.
Where is the registered office of CellCarta Biosciences?
According to the CBE register, the registered office of CellCarta Biosciences is in 6041 Charleroi.
What is the equity of CellCarta Biosciences?
At the close of the 2023 financial year, the equity of CellCarta Biosciences amounts to 1,047,926 €, a solvency of 4.7% of total assets.
How many people work at CellCarta Biosciences?
62.9 full-time equivalents on average according to the 2023 social balance sheet.
Who manages CellCarta Biosciences?
The register lists 4 active mandates at CellCarta Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is CellCarta Biosciences within its sector?
By total assets for 2023, CellCarta Biosciences ranks among the 100 largest of the 895 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of CellCarta Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →